Nuclear receptors reverse McGarry's vicious cycle to insulin resistance - PubMed (original) (raw)

Nuclear receptors reverse McGarry's vicious cycle to insulin resistance

David D Moore. Cell Metab. 2012.

Erratum in

Abstract

Several pathways and pathologies have been suggested as connections between obesity and diabetes, including inflammation of adipose and other tissues, toxic lipids, endoplasmic reticulum stress, and fatty liver. One specific proposal is that insulin resistance induces a vicious cycle in which hyperinsulinemia increases hepatic lipogenesis and exacerbates fatty liver, in turn further increasing insulin resistance. Here I suggest that reversing this cycle via suppression of the lipogenic transcription factor SREBP-1c is a common thread that connects the antidiabetic effects of a surprising number of nuclear hormone receptors, including CAR, LRH-1, TRβ, ERα, and FXR/SHP.

Copyright © 2012 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Proposed model for McGarry’s lipogenic vicious cycle, and its reversal

In the red, counterclockwise cycle, insulin resistance generates a self-reinforcing negative regulatory loop in which elevated insulin levels increase SREBP-1c expression and steatosis. This further decreases insulin sensitivity and increases in serum insulin levels to continue the negative cycle. Several NRs, including ERα CAR, LRH-1 TRβ and FXR/SHP act to decrease SREBP-1c expression, lowering steatosis and setting up a positive, anti-lipogenic cycle to improved insulin sensitivity.

References

    1. Abdelmalek MF, Diehl AM. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am. 2007;91:1125–1149. ix. - PubMed
    1. Amaro A, Fabbrini E, Kars M, Yue P, Schechtman K, Schonfeld G, Klein S. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology. 2010;139:149–153. - PMC - PubMed
    1. Amengual J, Ribot J, Bonet ML, Palou A. Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice. Cell Physiol Biochem. 2010;25:657–666. - PubMed
    1. Amorim BS, Ueta CB, Freitas BC, Nassif RJ, Gouveia CH, Christoffolete MA, Moriscot AS, Lancelloti CL, Llimona F, Barbeiro HV, et al. A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol. 2009;203:291–299. - PMC - PubMed
    1. Angelin B, Rudling M. Lipid lowering with thyroid hormone and thyromimetics. Curr Opin Lipidol. 2010;21:499–506. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources